| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
27,570 |
19,939 |
$924K |
| 99050 |
|
11,988 |
9,960 |
$162K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,021 |
1,971 |
$150K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,074 |
2,020 |
$141K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,213 |
1,186 |
$76K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,661 |
2,186 |
$47K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,249 |
2,185 |
$35K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
614 |
588 |
$26K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
505 |
500 |
$26K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
351 |
339 |
$21K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,549 |
1,331 |
$12K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,659 |
1,395 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
627 |
606 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
649 |
632 |
$8K |
| G9716 |
Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason |
6,588 |
6,368 |
$7K |
| 99000 |
|
1,760 |
1,441 |
$7K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
89 |
88 |
$6K |
| 99383 |
|
51 |
51 |
$4K |
| 96160 |
|
8,145 |
6,516 |
$4K |
| 99384 |
|
27 |
27 |
$2K |
| 90461 |
|
1,169 |
917 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
170 |
169 |
$2K |
| 99382 |
|
14 |
14 |
$835.40 |
| 86580 |
|
98 |
97 |
$739.42 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
102 |
99 |
$533.91 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,020 |
951 |
$499.97 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
133 |
133 |
$297.33 |
| 96161 |
|
6,773 |
5,157 |
$190.24 |
| 99429 |
|
12 |
12 |
$64.28 |
| 99051 |
|
199 |
181 |
$14.94 |
| 90651 |
|
420 |
417 |
$0.16 |
| 90620 |
|
57 |
57 |
$0.02 |
| 90686 |
|
116 |
115 |
$0.02 |
| 90734 |
|
171 |
169 |
$0.01 |
| 36415 |
Collection of venous blood by venipuncture |
465 |
432 |
$0.00 |
| 90697 |
|
42 |
41 |
$0.00 |
| 90696 |
|
15 |
15 |
$0.00 |
| 90723 |
|
13 |
13 |
$0.00 |
| 90680 |
|
12 |
12 |
$0.00 |
| 90715 |
|
84 |
84 |
$0.00 |
| 90710 |
|
52 |
52 |
$0.00 |
| 90670 |
|
133 |
133 |
$0.00 |
| 90633 |
|
86 |
86 |
$0.00 |
| 90671 |
|
93 |
92 |
$0.00 |
| 90648 |
|
27 |
27 |
$0.00 |